Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331☆.

Saved in:
Bibliographic Details
Title: Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331☆.
Authors: Spigel, D.R.1 David.spigel@sarahcannon.com, Vicente, D.2, Ciuleanu, T.E.3, Gettinger, S.4, Peters, S.5, Horn, L.6, Audigier-Valette, C.7, Pardo Aranda, N.8, Juan-Vidal, O.9, Cheng, Y.10, Zhang, H.11, Shi, M.12, Luft, A.13, Wolf, J.14, Antonia, S.1,15, Nakagawa, K.16, Fairchild, J.1,17, Baudelet, C.18, Pandya, D.19, Doshi, P.20
Source: Annals of Oncology. May2021, Vol. 32 Issue 5, p631-641. 11p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2021.01.071